Literature DB >> 8461280

Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.

B Dubrovsky1.   

Abstract

Cushing's disorder and depression present overlapping although not identical psychological symptomatology. In turn, a subset of patients with affective disorders present with hypercortisolemia and disturbances, specifically disinhibition, of the hypothalamic hypophysio adrenal axis (HHAA). Memory disturbances, in particular, biasing toward negative contents, overlapping sleep abnormalities (marked reduction of stages 3 and 4) increased fatigue and loss of energy, attentional deficits and irritability, are just part of the common symptomatology presented by patients with both Cushing's disorder and depression. All of these behavioral manifestations are known to be affected by adrenal steroid hormones. There is consensus that hippocampal structures are a main target for adrenal steroid hormones; hence, these neural regions are some of the most likely mediators of the effects of corticoadrenal steroids on behavior. This paper proposes that an imbalance of adrenal steroids and their metabolites may play a fundamental role in the psychophysiopathology of Cushing's and depressive disorders. The imbalance of these hormones, especially at limbic sites, could distort mood and memory content affecting cognition based on recollection and present experiences. Reestablishing an adrenal balance could therefore be considered as a therapeutic aid in a subset of depressive disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461280      PMCID: PMC1188470     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  124 in total

Review 1.  Kindling: the first decade.

Authors:  R Racine
Journal:  Neurosurgery       Date:  1978 Sep-Oct       Impact factor: 4.654

2.  Effect of depression on the speed of recall of pleasant and unpleasant experiences.

Authors:  G G Lloyd; W A Lishman
Journal:  Psychol Med       Date:  1975-05       Impact factor: 7.723

3.  Internalisation of gonadotrophin--receptor complex in ovarian luteal cells.

Authors:  P M Conn; M Conti; J P Harwood; M L Dufau; K J Catt
Journal:  Nature       Date:  1978-08-10       Impact factor: 49.962

4.  The central nervous system and Cushing's disease.

Authors:  D T Krieger
Journal:  Med Clin North Am       Date:  1978-03       Impact factor: 5.456

5.  Insulin binding sites on rat liver nuclear membranes: biochemical and immunofluorescent studies.

Authors:  A Horvat
Journal:  J Cell Physiol       Date:  1978-10       Impact factor: 6.384

6.  Reversibility of cerebral atrophy in anorexia nervosa and Cushing's syndrome.

Authors:  E R Heinz; J Martinez; A Haenggeli
Journal:  J Comput Assist Tomogr       Date:  1977-10       Impact factor: 1.826

Review 7.  Psychoneuroendocrinology of affective disorder: an overview.

Authors:  P G Ettigi; G M Brown
Journal:  Am J Psychiatry       Date:  1977-05       Impact factor: 18.112

8.  Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction.

Authors:  G C Curtis; J Mendels
Journal:  Arch Gen Psychiatry       Date:  1976-09

9.  Cerebral atrophy following ACTH therapy.

Authors:  T Okuno; M Ito; Y Konishi; M Yoshioka; Y Nakano
Journal:  J Comput Assist Tomogr       Date:  1980-02       Impact factor: 1.826

Review 10.  The role of glucocorticoid hormones as biological amplifiers.

Authors:  D K Granner
Journal:  Monogr Endocrinol       Date:  1979
View more
  5 in total

Review 1.  Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.

Authors:  N Sonino; G A Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Evolution of nervous systems and psychiatry: consequences of the vertical and horizontal duality of the evolutionary process.

Authors:  B Dubrovsky
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

3.  Glucocorticoid receptor dysfunction: consequences for the pathophysiology and treatment of mood disorders.

Authors:  Aju Abraham; Stuart Watson; Allan H Young
Journal:  Indian J Psychiatry       Date:  2003-04       Impact factor: 1.759

Review 4.  Drug-induced depression. Incidence, avoidance and management.

Authors:  S B Patten; E J Love
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

5.  Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort.

Authors:  Liang Feng; Chay-Hoon Tan; Reshma A Merchant; Tze-Pin Ng
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.